ACORN BIOVENTURES, L.P. — Form D/A
ACORN BIOVENTURES, L.P. of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2020-03-27. $199.5M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2020-03-27
- Form: D/A
- Accession: 0001766853-20-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1, 3C.7
- Amount sold: $199.5M
- Investors: 16
- Date of first sale: 2019-03-07
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-333917
Issuer
- Name: ACORN BIOVENTURES, L.P.
- CIK: 0001766853
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 420 Lexington Avenue, Suite 2626, NEW YORK, NY, 10170
- Phone: 212-299-4777
Officers, directors & promoters (1)
| Name | Role | Location |
|---|
| GENERAL PARTNER ACORN CAPITAL ADVISORS GP, LLC | Promoter | NEW YORK, NY |
Other filings by this issuer (1)
More